IDEAS home Printed from https://ideas.repec.org/r/oup/oxford/v5y1989i1p34-58.html
   My bibliography  Save this item

The Normative Economics of Health Care Finance and Provision

Citations

Blog mentions

As found by EconAcademics.org, the blog aggregator for Economics research:
  1. The potential of the super QALY to reconcile the key contentions in health economics
    by Chris Sampson in The Academic Health Economists' Blog on 2013-05-20 11:54:41

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Christine Godfrey, 2006. "Evidence-Based Illicit Drug Policy: The Potential Contribution of Economic Evaluation Techniques," De Economist, Springer, vol. 154(4), pages 563-580, December.
  2. David Parkin & Nancy Devlin, 2006. "Is there a case for using visual analogue scale valuations in cost‐utility analysis?," Health Economics, John Wiley & Sons, Ltd., vol. 15(7), pages 653-664, July.
  3. Wagstaff, Adam & Lindelow, Magnus, 2008. "Can insurance increase financial risk?: The curious case of health insurance in China," Journal of Health Economics, Elsevier, vol. 27(4), pages 990-1005, July.
  4. Philippe Tessier & Josselin Thuilliez, 2018. "Does freedom make a difference?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(8), pages 1189-1205, November.
  5. Philippe Batifoulier & John Latsis & Jacques Merchiers, 2010. "Les priorités de la prise en charge financière des soins. Une approche par la philosophie du besoin," EconomiX Working Papers 2010-2, University of Paris Nanterre, EconomiX.
  6. Anand, Paul & Dolan, Paul, 2005. "Equity, capabilities and health," Social Science & Medicine, Elsevier, vol. 60(2), pages 219-222, January.
  7. Magnus Lindelow, 2004. "The Utilization of Curative Health Care in Mozambique: Does Income Matter?," Development and Comp Systems 0409057, University Library of Munich, Germany.
  8. Fiebig, Denzil G. & Haas, Marion & Hossain, Ishrat & Street, Deborah J. & Viney, Rosalie, 2009. "Decisions about Pap tests: What influences women and providers?," Social Science & Medicine, Elsevier, vol. 68(10), pages 1766-1774, May.
  9. Culyer, Anthony J. & Evans, Robert G., 1996. "Mark Pauly on welfare economics: Normative rabbits from positive hats," Journal of Health Economics, Elsevier, vol. 15(2), pages 243-251, April.
  10. Tony J Culyer, 1995. "Equality of what in health policy? Conflicts between the contenders," Working Papers 142chedp, Centre for Health Economics, University of York.
  11. Tony J Culyer & Alan Wagstaff, 1991. "Need, equality and social justice," Working Papers 090chedp, Centre for Health Economics, University of York.
  12. Dolan, Paul & Edlin, Richard, 2002. "Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis?," Journal of Health Economics, Elsevier, vol. 21(5), pages 827-843, September.
  13. Weinstein, Milton C. & Manning, Willard Jr., 1997. "Theoretical issues in cost-effectiveness analysis," Journal of Health Economics, Elsevier, vol. 16(1), pages 121-128, February.
  14. Gravelle, Hugh & Siciliani, Luigi, 2008. "Ramsey waits: Allocating public health service resources when there is rationing by waiting," Journal of Health Economics, Elsevier, vol. 27(5), pages 1143-1154, September.
  15. Coast, Joanna & Flynn, Terry N. & Natarajan, Lucy & Sproston, Kerry & Lewis, Jane & Louviere, Jordan J. & Peters, Tim J., 2008. "Valuing the ICECAP capability index for older people," Social Science & Medicine, Elsevier, vol. 67(5), pages 874-882, September.
  16. Johanna Cook & Jeff Richardson & Andrew Street, 1994. "A cost utility analysis of treatment options for gallstone disease: Methodological issues and results," Health Economics, John Wiley & Sons, Ltd., vol. 3(3), pages 157-168, May.
  17. Zeynep Erkin & Matthew D. Bailey & Lisa M. Maillart & Andrew J. Schaefer & Mark S. Roberts, 2010. "Eliciting Patients' Revealed Preferences: An Inverse Markov Decision Process Approach," Decision Analysis, INFORMS, vol. 7(4), pages 358-365, December.
  18. Kalipso Chalkidou & Anthony Culyer & Bhash Naidoo & Peter Littlejohns, 2008. "Cost‐effective public health guidance: asking questions from the decision‐maker's viewpoint," Health Economics, John Wiley & Sons, Ltd., vol. 17(3), pages 441-448, March.
  19. Garber, Alan M. & Phelps, Charles E., 1997. "Economic foundations of cost-effectiveness analysis," Journal of Health Economics, Elsevier, vol. 16(1), pages 1-31, February.
  20. Ignacio Abásolo & Aki Tsuchiya, 2013. "Egalitarianism and Altruism in Health: To What Extent Are They Related?," Working Papers 2013003, The University of Sheffield, Department of Economics.
  21. Nolan, Brian, 1991. "The Utilisation and Financing of Health Services in Ireland," Research Series, Economic and Social Research Institute (ESRI), number GRS155, June.
  22. Jan Abel Olsen, 1997. "Aiding priority setting in health care: is there a role for the contingent valuation method?," Health Economics, John Wiley & Sons, Ltd., vol. 6(6), pages 603-612, November.
  23. Martin Chalkley & Hugh Gravelle & Nikita Jacob & Rita Santos & Luigi Siciliani, 2022. "This paper constitutes the first and foundational output of the ESHCRU2 project 3 - Analysis of purcher-provider contracts: modelling risk sharing and incentive implications. In this project, we have ," Working Papers 187cherp, Centre for Health Economics, University of York.
  24. Thomas Klose, 2003. "A utility‐theoretic model for QALYs and willingness to pay," Health Economics, John Wiley & Sons, Ltd., vol. 12(1), pages 17-31, January.
  25. Wildman, John & McMeekin, Peter & Grieve, Eleanor & Briggs, Andrew, 2016. "Economic evaluation of integrated new technologies for health and social care: Suggestions for policy makers, users and evaluators," Social Science & Medicine, Elsevier, vol. 169(C), pages 141-148.
  26. Berman, Peter, 1995. "Health sector reform: making health development sustainable," Health Policy, Elsevier, vol. 32(1-3), pages 13-28.
  27. Robert Bartels & Denzil Fiebig & Arthur Soest, 2006. "Consumers and experts: an econometric analysis of the demand for water heaters," Empirical Economics, Springer, vol. 31(2), pages 369-391, June.
  28. Dolan, Paul & Tsuchiya, Aki, 2009. "The social welfare function and individual responsibility: Some theoretical issues and empirical evidence," Journal of Health Economics, Elsevier, vol. 28(1), pages 210-220, January.
  29. Paula K. Lorgelly & Kenny D. Lawson & Elisabeth A.L. Fenwick & Andrew H. Briggs, 2010. "Outcome Measurement in Economic Evaluations of Public Health Interventions: a Role for the Capability Approach?," IJERPH, MDPI, vol. 7(5), pages 1-16, May.
  30. Hansen, B. O. & Hougaard, J. L. & Keiding, H. & Osterdal, L. P., 2004. "On the possibility of a bridge between CBA and CEA: comments on a paper by Dolan and Edlin," Journal of Health Economics, Elsevier, vol. 23(5), pages 887-898, September.
  31. Engel, Lidia & Bryan, Stirling & Noonan, Vanessa K. & Whitehurst, David G.T., 2018. "Using path analysis to investigate the relationships between standardized instruments that measure health-related quality of life, capability wellbeing and subjective wellbeing: An application in the ," Social Science & Medicine, Elsevier, vol. 213(C), pages 154-164.
  32. Kirsteen Smith & Ken Wright, 1994. "Principles and agents in social care: who's on the case and for whom?," Working Papers 123chedp, Centre for Health Economics, University of York.
  33. Abasolo, Ignacio & Tsuchiya, Aki, 2004. "Exploring social welfare functions and violation of monotonicity: an example from inequalities in health," Journal of Health Economics, Elsevier, vol. 23(2), pages 313-329, March.
  34. Mihaela TOMAZIU-TODOSIA & Iuliana- Claudia MIHALACHE & Felicia- Cătălina APETROI (RĂCOARE), 2020. "Financial resources - an important aspect of increasing the performance of the health care sector in Romania," CES Working Papers, Centre for European Studies, Alexandru Ioan Cuza University, vol. 12(1), pages 89-99, May.
  35. Richard Cookson, 2005. "QALYs and the capability approach," Health Economics, John Wiley & Sons, Ltd., vol. 14(8), pages 817-829, August.
  36. Stephen Birch & Joy Melnikow & Miriam Kuppermann, 2003. "Conservative versus aggressive follow up of mildly abnormal Pap smears: Testing for process utility," Health Economics, John Wiley & Sons, Ltd., vol. 12(10), pages 879-884, October.
  37. Coast, Joanna & Smith, Richard D. & Lorgelly, Paula, 2008. "Welfarism, extra-welfarism and capability: The spread of ideas in health economics," Social Science & Medicine, Elsevier, vol. 67(7), pages 1190-1198, October.
  38. Paul Mark Mitchell & Sridhar Venkatapuram & Jeff Richardson & Angelo Iezzi & Joanna Coast, 2017. "Are Quality-Adjusted Life Years a Good Proxy Measure of Individual Capabilities?," PharmacoEconomics, Springer, vol. 35(6), pages 637-646, June.
  39. Kanavos, Panos & Visintin, Erica & Gentilini, Arianna, 2023. "Algorithms and heuristics of health technology assessments: A retrospective analysis of factors associated with HTA outcomes for new drugs across seven OECD countries," Social Science & Medicine, Elsevier, vol. 331(C).
  40. Rachel Baker & Angela Robinson, 2004. "Responses to standard gambles: are preferences ‘well constructed’?," Health Economics, John Wiley & Sons, Ltd., vol. 13(1), pages 37-48, January.
  41. David Canning, 2007. "Valuing Lives Equally and Welfare Economics," PGDA Working Papers 2707, Program on the Global Demography of Aging.
  42. Adomah-Afari, Augustine & Chandler, Jim A., 2018. "The role of government and community in the scaling up and sustainability of mutual health organisations: An exploratory study in Ghana," Social Science & Medicine, Elsevier, vol. 207(C), pages 25-37.
  43. Adam Oliver, 2005. "The English National Health Service: 1979‐2005," Health Economics, John Wiley & Sons, Ltd., vol. 14(S1), pages 75-99, September.
  44. Richard Smith & Paula Lorgelly & Hareth Al-Janabi & Sridhar Venkatapuram & Joanna Coast, 2012. "The Capability Approach: An Alternative Evaluation Paradigm for Health Economics?," Chapters, in: Andrew M. Jones (ed.), The Elgar Companion to Health Economics, Second Edition, chapter 39, Edward Elgar Publishing.
  45. Stolpe, Michael, 2003. "Ressourcen und Ergebnisse der globalen Gesundheitsökonomie: Einführung und Überblick," Kiel Working Papers 1177, Kiel Institute for the World Economy (IfW Kiel).
  46. Ramses H. Abul Naga & Karine Lamiraud, 2008. "Catastrophic Health ExpenditureandHousehold Well-Being," STICERD - Distributional Analysis Research Programme Papers 098, Suntory and Toyota International Centres for Economics and Related Disciplines, LSE.
  47. Kevin Haninger & James K. Hammitt, 2011. "Diminishing Willingness to Pay per Quality‐Adjusted Life Year: Valuing Acute Foodborne Illness," Risk Analysis, John Wiley & Sons, vol. 31(9), pages 1363-1380, September.
  48. Bleichrodt, Han, 1997. "Health utility indices and equity considerations," Journal of Health Economics, Elsevier, vol. 16(1), pages 65-91, February.
  49. Bleichrodt, Han & Quiggin, John, 2013. "Capabilities as menus: A non-welfarist basis for QALY evaluation," Journal of Health Economics, Elsevier, vol. 32(1), pages 128-137.
  50. Mansdotter, Anna & Lindholm, Lars & Ohman, Ann, 2004. "Women, men and public health--how the choice of normative theory affects resource allocation," Health Policy, Elsevier, vol. 69(3), pages 351-364, September.
  51. Magnus Lindelow, 2003. "The Utilization of Curative Health Care in Mozambique: Does Income Matter?," Economics Series Working Papers WPS/2004-11, University of Oxford, Department of Economics.
  52. Neuman, Einat & Neuman, Shoshana, 2007. "Agency in Health-Care: Are Medical Care-Givers Perfect Agents?," IZA Discussion Papers 2727, Institute of Labor Economics (IZA).
  53. Olsen, Jan Abel & Eidem, Jan Inge, 2003. "An inquiry into the size of health charities: the case of Norwegian patient organisations," Journal of Behavioral and Experimental Economics (formerly The Journal of Socio-Economics), Elsevier, vol. 32(4), pages 457-466, September.
  54. Bengt Liljas, 2010. "On the welfare theoretic foundation of cost-effectiveness analysis—the case when survival is not affected," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 11(1), pages 5-13, February.
  55. Jong‐Yi Wang & Janice C. Probst & Carleen H. Stoskopf & Jimy M. Sanders & James F. McTigue, 2011. "Information asymmetry and performance tilting in hospitals: a national empirical study," Health Economics, John Wiley & Sons, Ltd., vol. 20(12), pages 1487-1506, December.
  56. Schneider, Paul, 2019. "Social tariffs and democratic choice – do population-based health state values reflect the will of the people?," SocArXiv 2qvjb, Center for Open Science.
  57. Sun-Young Kim & Sue Goldie, 2008. "Cost-Effectiveness Analyses of Vaccination Programmes," PharmacoEconomics, Springer, vol. 26(3), pages 191-215, March.
  58. Don Husereau & Anthony Culyer & Peter Neumann & Philip Jacobs, 2015. "How do Economic Evaluations Inform Health Policy Decisions for Treatment and Prevention in Canada and the United States?," Applied Health Economics and Health Policy, Springer, vol. 13(3), pages 273-279, June.
  59. Mæstad, Ottar & Norheim, Ole Frithjof, 2009. "Eliciting people's preferences for the distribution of health: A procedure for a more precise estimation of distributional weights," Journal of Health Economics, Elsevier, vol. 28(3), pages 570-577, May.
  60. Paula Lorgelly, 2015. "Choice of Outcome Measure in an Economic Evaluation: A Potential Role for the Capability Approach," PharmacoEconomics, Springer, vol. 33(8), pages 849-855, August.
  61. Cam Donaldson & Stephen Birch & Amiram Gafni, 2002. "The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes," Health Economics, John Wiley & Sons, Ltd., vol. 11(1), pages 55-70, January.
  62. Bleichrodt, Han & Diecidue, Enrico & Quiggin, John, 2004. "Equity weights in the allocation of health care: the rank-dependent QALY model," Journal of Health Economics, Elsevier, vol. 23(1), pages 157-171, January.
  63. Paul Anand, 2005. "QALYs and capabilities: a comment on Cookson," Health Economics, John Wiley & Sons, Ltd., vol. 14(12), pages 1283-1286, December.
  64. Böhm, Katharina & Schmid, Achim & Götze, Ralf & Landwehr, Claudia & Rothgang, Heinz, 2012. "Classifying OECD healthcare systems: A deductive approach," TranState Working Papers 165, University of Bremen, Collaborative Research Center 597: Transformations of the State.
  65. Jane Hall, 1997. ""Unorthodox, troublesome, dangerous and disobedient": a feminist perspective on health economics, CHERE Discussion Paper No 33," Discussion Papers 33, CHERE, University of Technology, Sydney.
  66. Paul Anand & Laurence S. J. Roope & Anthony J. Culyer & Ron Smith, 2020. "Disability and multidimensional quality of life: A capability approach to health status assessment," Health Economics, John Wiley & Sons, Ltd., vol. 29(7), pages 748-765, July.
  67. Jacco Thijssen, 2007. "Ramsey Waits: A Computational Study on General Equilibrium Pricing of Derivative Securities," Discussion Papers 07/16, Department of Economics, University of York.
  68. Joao Pereira, 1989. "What does equity in health mean?," Working Papers 061chedp, Centre for Health Economics, University of York.
  69. Claxton, Karl, 1999. "The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies," Journal of Health Economics, Elsevier, vol. 18(3), pages 341-364, June.
  70. Ramses H. Abul Naga & Karine Lamiraud, 2008. "Catastrophic Health ExpenditureandHousehold Well-Being," STICERD - Distributional Analysis Research Programme Papers 098, Suntory and Toyota International Centres for Economics and Related Disciplines, LSE.
  71. Elsa Marques & Sian Noble & Ashley W. Blom & William Hollingworth, 2014. "Disclosing Total Waiting Times For Joint Replacement: Evidence From The English Nhs Using Linked Hes Data," Health Economics, John Wiley & Sons, Ltd., vol. 23(7), pages 806-820, July.
  72. O'Neill, Ciaran & Largey, Ann, 1998. "The role of quality standards-accreditation in redressing asymmetry of information in health care markets," Health Policy, Elsevier, vol. 45(1), pages 33-45, July.
  73. Mark Sculpher & Karl Claxton, 2012. "Real Economics Needs to Reflect Real Decisions," PharmacoEconomics, Springer, vol. 30(2), pages 133-136, February.
  74. Månsdotter, Anna & Lindholm, Lars & Lundberg, Michael, 2006. "Health, wealth and fairness based on gender: The support for ethical principles," Social Science & Medicine, Elsevier, vol. 62(9), pages 2327-2335, May.
  75. Mitchell, Paul Mark & Roberts, Tracy E. & Barton, Pelham M. & Coast, Joanna, 2015. "Assessing sufficient capability: A new approach to economic evaluation," Social Science & Medicine, Elsevier, vol. 139(C), pages 71-79.
  76. Richard D. Smith & Tracey H. Sach, 2009. "Contingent valuation: (still) on the road to nowhere?," Health Economics, John Wiley & Sons, Ltd., vol. 18(8), pages 863-866, August.
  77. Hareth Al‐Janabi & Job Van Exel & Werner Brouwer & Caroline Trotter & Linda Glennie & Laurie Hannigan & Joanna Coast, 2016. "Measuring Health Spillovers for Economic Evaluation: A Case Study in Meningitis," Health Economics, John Wiley & Sons, Ltd., vol. 25(12), pages 1529-1544, December.
  78. Alessandro Petretto, 2013. "On the Fuzzy Boundaries between Public and Private in Health-Care Organization and Funding Systems," Rivista di Politica Economica, SIPI Spa, issue 1, pages 327-370, January-M.
  79. Brouwer, Werner B. F. & Koopmanschap, Marc A., 2000. "On the economic foundations of CEA. Ladies and gentlemen, take your positions!," Journal of Health Economics, Elsevier, vol. 19(4), pages 439-459, July.
  80. Iuliana-Claudia Mihalache & Felicia-Cä‚Tä‚Lina Apetroi (Rä‚Coare), 2020. "The Evolution Of The Financing Of Health Services In Romania, From The Semashko Model To The Bismarck Model," Review of Economic and Business Studies, Alexandru Ioan Cuza University, Faculty of Economics and Business Administration, issue 25, pages 137-147, June.
  81. Paul Mark Mitchell & Samantha Husbands & Sarah Byford & Philip Kinghorn & Cara Bailey & Tim J. Peters & Joanna Coast, 2021. "Challenges in developing capability measures for children and young people for use in the economic evaluation of health and care interventions," Health Economics, John Wiley & Sons, Ltd., vol. 30(9), pages 1990-2003, September.
  82. Karsu, Özlem & Morton, Alec & Argyris, Nikos, 2018. "Capturing preferences for inequality aversion in decision support," European Journal of Operational Research, Elsevier, vol. 264(2), pages 686-706.
  83. Henry, Edward & Cullinan, John, 2021. "Mental health spillovers from serious family illness: Doubly robust estimation using EQ-5D-5L population normative data," Social Science & Medicine, Elsevier, vol. 279(C).
  84. McClellan, Mark & Skinner, Jonathan, 2006. "The incidence of Medicare," Journal of Public Economics, Elsevier, vol. 90(1-2), pages 257-276, January.
  85. Brouwer, Werner B.F. & Culyer, Anthony J. & van Exel, N. Job A. & Rutten, Frans F.H., 2008. "Welfarism vs. extra-welfarism," Journal of Health Economics, Elsevier, vol. 27(2), pages 325-338, March.
  86. Karl Claxton & Mark Sculpher & Tony Culyer, 2007. "Mark versus Luke? Appropriate Methods for the Evaluation of Public Health Interventions," Working Papers 031cherp, Centre for Health Economics, University of York.
  87. Birch, Stephen & Gafni, Amiram, 2003. "Economics and the evaluation of health care programmes: generalisability of methods and implications for generalisability of results," Health Policy, Elsevier, vol. 64(2), pages 207-219, May.
  88. Bleichrodt, Han & Quiggin, John, 1999. "Life-cycle preferences over consumption and health: when is cost-effectiveness analysis equivalent to cost-benefit analysis?," Journal of Health Economics, Elsevier, vol. 18(6), pages 681-708, December.
  89. Lega, Federico & DePietro, Carlo, 2005. "Converging patterns in hospital organization: beyond the professional bureaucracy," Health Policy, Elsevier, vol. 74(3), pages 261-281, November.
  90. Heinrich, Ralph P. & Koop, Michael J. & Boss, Alfred & Gröhn, Andreas & Kopp, Andreas & Rosenschon, Astrid & Schmidt, Rainer, 1996. "Sozialpolitik im Transformationsprozeß Mittel- und Osteuropas," Open Access Publications from Kiel Institute for the World Economy 860, Kiel Institute for the World Economy (IfW Kiel).
  91. Antonio Nicita, 2004. "Il pendolo delle riforme nei sistemi sanitari europei," Working Papers CERM 05-2004, Competitività, Regole, Mercati (CERM).
  92. Ruben Andreas Sakowsky, 2021. "Disentangling the welfarism/extra‐welfarism distinction: Towards a more fine‐grained categorization," Health Economics, John Wiley & Sons, Ltd., vol. 30(9), pages 2307-2311, September.
  93. Andrew Jones;Alan Duncan, 1995. "Hypothecated Health Taxes: An evaluation of recent proposals," Monograph 000413, Office of Health Economics.
  94. Böhm, Katharina & Schmid, Achim & Götze, Ralf & Landwehr, Claudia & Rothgang, Heinz, 2013. "Five types of OECD healthcare systems: Empirical results of a deductive classification," Health Policy, Elsevier, vol. 113(3), pages 258-269.
  95. Morton, Alec, 2014. "Aversion to health inequalities in healthcare prioritisation: A multicriteria optimisation perspective," Journal of Health Economics, Elsevier, vol. 36(C), pages 164-173.
  96. Richardson, Jeff & McKie, John, 2007. "Economic evaluation of services for a National Health Scheme: The case for a fairness-based framework," Journal of Health Economics, Elsevier, vol. 26(4), pages 785-799, July.
  97. Gravelle, Hugh & Siciliani, Luigi, 2008. "Optimal quality, waits and charges in health insurance," Journal of Health Economics, Elsevier, vol. 27(3), pages 663-674, May.
  98. repec:dau:papers:123456789/5993 is not listed on IDEAS
  99. Coast, Joanna, 2009. "Maximisation in extra-welfarism: A critique of the current position in health economics," Social Science & Medicine, Elsevier, vol. 69(5), pages 786-792, September.
  100. Admassu N. Lamu & Jan Abel Olsen, 2018. "Yes, health is important, but as much for its importance via social life: The direct and indirect effects of health on subjective well‐being in chronically ill individuals," Health Economics, John Wiley & Sons, Ltd., vol. 27(1), pages 209-222, January.
  101. Paul Peter Schneider, 2021. "Social tariffs and democratic choice—Do population‐based health state values reflect the will of the people?," Health Economics, John Wiley & Sons, Ltd., vol. 30(1), pages 104-112, January.
  102. Chris Skedgel & Allan Wailoo & Ron Akehurst, 2015. "Societal Preferences for Distributive Justice in the Allocation of Health Care Resources," Medical Decision Making, , vol. 35(1), pages 94-105, January.
  103. Bengt Liljas & Göran S. Karlsson & Nils‐Olov Stålhammar, 2008. "On future non‐medical costs in economic evaluations," Health Economics, John Wiley & Sons, Ltd., vol. 17(5), pages 579-591, May.
  104. Alexis Habiyaremye, 2022. "Optimal Patent Protection Length for Vital Pharmaceuticals in the Age of COVID-19," Sustainability, MDPI, vol. 14(16), pages 1-16, August.
  105. Joanna Coast & Richard Smith & Paula Lorgelly, 2008. "Should the capability approach be applied in Health Economics?," Health Economics, John Wiley & Sons, Ltd., vol. 17(6), pages 667-670, June.
  106. Richardson, Jeff & McKie, John, 2005. "Empiricism, ethics and orthodox economic theory: what is the appropriate basis for decision-making in the health sector?," Social Science & Medicine, Elsevier, vol. 60(2), pages 265-275, January.
  107. Lauren E. Cipriano & Thomas A. Weber, 2018. "Population-level intervention and information collection in dynamic healthcare policy," Health Care Management Science, Springer, vol. 21(4), pages 604-631, December.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.